Motryx Inc.
$251,455.00 CAD
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2021-2022
- Agreement period
- July 18, 2021 – January 31, 2023
- Reference
- nrc-cnrc:172-2021-2022-Q2-975582
Published purpose
VitalQC allows laboratories to quantify the clinical impact on blood samples as they are being transported. This is the first step in commercializing VitalQC; however, broad market reach is only possible by integrating tools that customers can use to improve the systems and ensure low impact on sample quality. VitalQC provides clinical predictions, indicating when pneumatic tube systems are and are not suitable for blood transportation. In the event VitalQC identifies an unsuitable, customers and partners may require additional information as to how to fix their system in order to reduce impact to specimens. Motryx will address this problem by providing a repeatable framework for the troubleshooting of problems identified.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.